These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 19908299

  • 1. Trilateral retinoblastoma: potentially curable with intensive chemotherapy.
    Dunkel IJ, Jubran RF, Gururangan S, Chantada GL, Finlay JL, Goldman S, Khakoo Y, O'Brien JM, Orjuela M, Rodriguez-Galindo C, Souweidane MM, Abramson DH.
    Pediatr Blood Cancer; 2010 Mar; 54(3):384-7. PubMed ID: 19908299
    [Abstract] [Full Text] [Related]

  • 2. High-dose chemotherapy with autologous hematopoietic stem cell rescue for stage 4B retinoblastoma.
    Dunkel IJ, Chan HS, Jubran R, Chantada GL, Goldman S, Chintagumpala M, Khakoo Y, Abramson DH.
    Pediatr Blood Cancer; 2010 Jul 15; 55(1):149-52. PubMed ID: 20486181
    [Abstract] [Full Text] [Related]

  • 3. Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma.
    Dunkel IJ, Khakoo Y, Kernan NA, Gershon T, Gilheeney S, Lyden DC, Wolden SL, Orjuela M, Gardner SL, Abramson DH.
    Pediatr Blood Cancer; 2010 Jul 15; 55(1):55-9. PubMed ID: 20486171
    [Abstract] [Full Text] [Related]

  • 4. Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue.
    Zacharoulis S, Levy A, Chi SN, Gardner S, Rosenblum M, Miller DC, Dunkel I, Diez B, Sposto R, Ji L, Asgharzadeh S, Hukin J, Belasco J, Dubowy R, Kellie S, Termuhlen A, Finlay J.
    Pediatr Blood Cancer; 2007 Jul 15; 49(1):34-40. PubMed ID: 16874765
    [Abstract] [Full Text] [Related]

  • 5. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May 15; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 6. Trilateral retinoblastoma with pituitary-hypothalamic dysfunction.
    Dai S, Dimaras H, Héon E, Budning A, Doyle J, Halliday W, Drake J, Gallie BL, Chan HS.
    Ophthalmic Genet; 2008 Sep 15; 29(3):120-5. PubMed ID: 18766991
    [Abstract] [Full Text] [Related]

  • 7. Trilateral retinoblastoma.
    Antoneli CB, Ribeiro Kde C, Sakamoto LH, Chojniak MM, Novaes PE, Arias VE.
    Pediatr Blood Cancer; 2007 Mar 15; 48(3):306-10. PubMed ID: 16572402
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Double high-dose therapy for Hodgkin's disease with dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP) prior to high-dose melphalan and autologous stem cell transplantation.
    Stewart DA, Guo D, Glück S, Morris D, Chaudhry A, deMetz C, Klassen J, Brown CB, Russell JA.
    Bone Marrow Transplant; 2000 Aug 15; 26(4):383-8. PubMed ID: 10982284
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Thiotepa/topotecan/carboplatin with autologous stem cell rescue in recurrent/refractory/poor prognosis pediatric malignancies of the central nervous system.
    Gilheeney SW, Khakoo Y, Souweidane M, Wolden S, Boulad F, Dunkel IJ.
    Pediatr Blood Cancer; 2010 Apr 15; 54(4):591-5. PubMed ID: 19998470
    [Abstract] [Full Text] [Related]

  • 19. Successful treatment of trilateral retinoblastoma with conventional and high-dose chemotherapy plus radiotherapy: a case report.
    De Ioris MA, Fidani P, Munier FL, Serra A, Ilari I, Popovic MB, Natali G, Secco DE, Cozza R.
    J Pediatr Hematol Oncol; 2010 Nov 15; 32(8):e343-5. PubMed ID: 20881869
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.